M. M. Samorai

M. M. Samorai

Auto-generated profile, based on publicly available information

M. M. Samorai

Bila Tserkva National Agrarian University, Bila Tserkva, Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2026 in Theoretical and Applied Veterinary Medicine
Verified
Journal Article
Open access
AMA. Yu. Melnyk
A. Yu. Melnyk
ODO. M. Dubin
O. M. Dubin
VSV. S. Sakara
V. S. Sakara
NVN. V. Vovkotrub
N. V. Vovkotrub
OCO. V. Chub
O. V. Chub
BBB. P. Bilyk
B. P. Bilyk
This study evaluated the effect of feed additive administration on the functional state of the liver and kidneys in piglets, based on indicators of protein, nitrogen, and lipid metabolism, as well as the activity of key enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The experiment was carried out using piglets (35-days) from a farm in Kyiv region during 2023–2024. Animals were separated to control and experimental (n=6) groups. Blood biochemical parameters in both groups were within normal ranges and showed no significant differences before administration. After the first administration, the experimental group demonstrated an increase in total protein level. By the second blood sampling, the concentration had risen to 72.7 ± 0.99 g/L (P<0.1), and by the third to 76.2±1.21 g/L (P<0.05), with albumin levels reaching 41.55 ± 0.65% and 44.22 ± 0.17% (P<0.001), respectively, while the control group remained unaltered. These results indicate support of the liver’s albumin-synthesizing function under the influence of the preparation. Blood serum urea levels remained unchanged in both groups throughout the study, staying within the physiological norm, confirming the absence of negative effects on nitrogen metabolism. AST and ALT activities in the experimental group remained unaltered, whereas a gradual increase in AST was observed in the control group, indicating a better condition of hepatocytes in the treated animals. Creatinine concentrations were within normal limits in both groups, but statistically lower in the experimental group (P<0.05), further confirming the absence of nephrotoxic effects. Particular attention was paid to lipid metabolism indicators: in the experimental group, cholesterol levels significantly decreased to 1.70 ± 0.03 mmol/L (P<0.01) after two administrations, while remaining unchanged in the control group. The reduction of cholesterol within physiological limits is likely associated with activation of bile secretion and improvement of lipid metabolism processes rather than liver pathology, as supported by other biochemical parameters. Taking together, obtained results evidence that.

22 August 2020 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
YMYe. Mostovyi
Ye. Mostovyi
VHV. Holovakha
V. Holovakha
OPO. Piddubniak
O. Piddubniak
SSS. Sliusarenko
S. Sliusarenko
ASA. Sliusarenko
A. Sliusarenko
MSM. Samorai
M. Samorai
One of the most common and poorly understood diseases in dogs and cats is enteropathy with PLE.  The disease occurs, according to studies, in dogs of 2-6 years old breeds: Yorkshire terrier, German shepherd, and Golden Retriever. The disease in most cases is manifested by anorexia, polydipsia, diarrhea, fever up to 39.7 °C, tachycardia (145–170 bpm), and abdominal pain. In sick dogs, leucocytosis (21.0 ± 0.50 g/l), thrombocytosis (480.0 ± 10.13 g/l), oligocythaemia (4.8 ± 0.12 T/l), oligochromemia (109.0 ± 5.06 g/l), decrease in haematocrit value (29.0 ± 1.21 % in healthy people 42.3 ± 0.65 %). In a biochemical study of blood in dogs with enteropathy with PLE, hypoproteinaemia (38.2 ± 0.65 g/l), hypoalbuminemia (9.6 ± 0.61 g/l); hyperazotemia (8.6 ± 0.37 mmol/l), hypercholesterolemia (8.0 ± 0.23 mmol/l), hyperenzymemia of LF (ALP) and ALT (alanine aminotransferase), hyponatremia, hypokalaemia, hypochloraemia, decreased blood pH values (7.26 ± 0.013), HCO3- (15.3 ± 0.71 mmol/L) and AG (2.85 ± 0.084 mmol/L, in healthy people 14.3 ± 1.17 mmol/L). The diagnosis of enteropathy with PLE was confirmed by studies in feces of α1-antitrypsin, which in sick dogs with PLE was more than 22 mg/dL (in clinically healthy dogs up to 18 mg/dL). A treatment regimen with trometamol, Xylat, Disparkol, Voluven, Reopoliglukin, Maropitant, prednisolone, α-lysine escinat, albumin, Presorb and feed additives Vivonex Ten Elemental and Royal Canin Recoveri promotes the recovery of dogs, prevents their death. Under the action of drugs, erythro- and leuсocytopoiesis, protein-synthesizing (the content of total protein and albumin increased by 34.3 and 246.9 %, respectively) and urea-forming functions of hepatocytes improves. We have developed and tested a treatment scheme that restores the acid-base balance of the body, as indicated by the physiological values of blood pH, bicarbonates, anion gap (AG), Na+, K+, Cl- and Mg+.